Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987727 | SCV001137161 | pathogenic | Retinitis pigmentosa 25 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001382289 | SCV001580971 | pathogenic | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu1551*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 802235). For these reasons, this variant has been classified as Pathogenic. |
DBGen Ocular Genomics | RCV000987727 | SCV001816116 | pathogenic | Retinitis pigmentosa 25 | 2021-06-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000987727 | SCV004195237 | likely pathogenic | Retinitis pigmentosa 25 | 2024-01-24 | criteria provided, single submitter | clinical testing |